Eye on Washington

Article

When the new Congress gets down to business this month, change will be in the air. With majorities in the House and, maybe, the Senate, the Democrats will have an opportunity to enact their vision of health care reform. It will be interesting to see what they do with it. For starters, incoming House Speaker Nancy Pelosi has already promised to introduce legislation that would allow the Centers for Medicare and Medicaid Services (CMS) to negotiate discounts on drug prices and to provide federal funding for stem cell research.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
© 2025 MJH Life Sciences

All rights reserved.